The rationale for immunotherapy in respiratory allergies.
D000906:Antibodies / Q000502:physiology; D004311:Double-Blind Method; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007073:Immunoglobulin E / Q000032:analysis / Q000502:physiology; D007074:Immunoglobulin G / Q000032:analysis; D007167:Immunotherapy; D010919:Placebos; D011058:Pollen; D011852:Radioallergosorbent Test; D011863:Radioimmunoassay; D012130:Respiratory Hypersensitivity / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*; D013601:T-Lymphocytes / Q000502:physiology
D000906:Antibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D010919:Placebos; D007073:Immunoglobulin E